News | June 22, 2017

Oxford Immunotec Announces National Reimbursement For The T-SPOT®.TB Test In France OXFORD, United Kingdom and MARLBOROUGH, Mass., June 22, 2017 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on...

News | June 13, 2017

Kyruus Enhances Its Clinical Leadership with New Chief Medical Officer, Erin Jospe, M.D. Boston, MA – Kyruus, a leader in provider search and scheduling solutions for health systems, announced today that Erin Jospe, M.D., has joined its leadership team as the...

News | June 15, 2017

Oxford Immunotec Announces Favorable Claim Construction Ruling in Patent Infringement Litigation OXFORD, United Kingdom and MARLBOROUGH, Mass., June 15, 2017 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company...

News | June 6, 2017

Neuronetics, Inc. Raises $15 Million in Series G Equity Financing, Led by Ascension Ventures Capital will help expand clinical adoption of NeuroStar® Advanced Therapy, the company’s market-leading transcranial magnetic stimulation (TMS) treatment MALVERN,...

News | June 13, 2017

AbbVie and Principia Annouce Collaboration on Oral Immunoproteasome Inhibitors NORTH CHICAGO, Ill. and SOUTH SAN FRANCISCO, Calif., June 13, 2017 – AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Principia Biopharma Inc., a private, clinical-stage...
Donec leo venenatis Phasellus risus. dapibus